GlaxoSmithKline will partner with Merck KGaA, Darmstadt, to co-develop and co-commercialize the cancer immunotherapy candidate M7824 (bintrafusp alfa), through a collaboration that could generate more than €3.7 billion ($4.2 billion) for German...
Ambrosia charges $8,000 to fill your veins with the blood of young people to defeat aging, and is now accepting PayPal payments online. The company recently completed a clinical trial, but hasn't published results.
Matt Kalaycio, MDHT @sghmd. We transplant umbilical cord blood and see no anti-aging effects. This is a fake & dangerous procedure.